Cargando…
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
Global deployment of an effective and safe vaccine is necessary to curtail the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we evaluated a Newcastle disease virus (NDV)-based vectored-vaccine in mice and hamsters for its immunogeni...
Autores principales: | Park, Jun-Gyu, Oladunni, Fatai S., Rohaim, Mohammed A., Whittingham-Dowd, Jayde, Tollitt, James, Hodges, Matthew D.J., Fathallah, Nadin, Assas, Muhsref Bakri, Alhazmi, Wafaa, Almilaibary, Abdullah, Iqbal, Munir, Chang, Pengxiang, Escalona, Renee, Shivanna, Vinay, Torrelles, Jordi B., Worthington, John J., Jackson-Jones, Lucy H., Martinez-Sobrido, Luis, Munir, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332743/ https://www.ncbi.nlm.nih.gov/pubmed/34368648 http://dx.doi.org/10.1016/j.isci.2021.102941 |
Ejemplares similares
-
Intestinal epithelial suppressor of cytokine signaling 3 (SOCS3) impacts on mucosal homeostasis in a model of chronic inflammation
por: Shaw, Elisabeth J., et al.
Publicado: (2017) -
Equine Influenza Virus and Vaccines
por: Oladunni, Fatai S., et al.
Publicado: (2021) -
A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2
por: Rohaim, Mohammed A., et al.
Publicado: (2020) -
Anti-migraine agents from an immunological point of view
por: Assas, Mushref Bakri
Publicado: (2021) -
Correction to: Anti-migraine agents from an immunological point of view
por: Assas, Mushref Bakri
Publicado: (2021)